Skip to content

Randomized Controlled Clinical Trial of the Brain-Shaking Technique in Mongolian Medicine for Treating Concussions

Randomized Controlled Clinical Trial of the Brain-Shaking Technique in Mongolian Medicine for Treating Concussions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001324
Enrollment
Unknown
Registered
2026-05-26
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussions

Interventions

treatment group : brain-shaking technique and conventional Western medicine
control group :conventional Western medical treatment

Sponsors

International Mongolian Hospital of Inner Mongolia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (1) Meets the diagnostic criteria for concussion in either Mongolian or Western medicine. (2) Age 18–75 years, no gender restrictions. (3) Diagnosis confirmed within 72 hours of injury. (4) Voluntarily agrees to participate in this treatment, cooperates with all assessments during treatment, and signs an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1) Concurrent severe hepatic or renal failure (ALT/AST > 2 times the upper limit of normal, Cr > upper limit of normal), heart failure, malignant tumors, or other serious diseases. (2) Pregnant women, lactating women, or those planning pregnancy. (3) Patients with severe traumatic brain injury (e.g., skull fracture, acute intracranial hemorrhage), impaired consciousness, or psychiatric disorders. (4) Contraindications for concussion therapy (e.g., intracranial space-occupying lesions, severe cerebral vascular malformations). (5) Individuals with allergies to the investigational drug. (6) Participants who have received other traditional Chinese/ethnic medicine treatments to the head (e.g., acupuncture, massage) or participated in other drug clinical trials within the past month. (7) Legally disabled patients (blind, deaf, mute, intellectually disabled) or those with poor compliance (e.g., unable to attend follow-up appointments on schedule).

Design outcomes

Primary

MeasureTime frame
Post-Concussion Symptom Scale (PCSS);

Secondary

MeasureTime frame
Mongolian Medicine Syndrome Score;Pain score (VAS);Quality of life score (SF-36);

Countries

China

Contacts

Public ContactNashundalai

International Mongolian Hospital of Inner Mongolia

1045312506@qq.com13848913897

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026